August 30, 2019 by Steve Blade
According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-e. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for dual chamber prefilled syringes manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section. Dual chamber prefilled syringes have evolved to the stage where they are functionally useful for the packaging of lyophilized small volume parental drugs.
Glass will remain preferred product material for dual chamber prefilled syringes, mainly because of its non-reactive nature, and properties such as chemical and heat resistance. However sales of glass prefilled syringes will witness a comparatively slower expansion than plastic prefilled syringes through 2026.
For More Details - A sample of this report is available upon request here -
Key Takeaways from Fact.MR’s Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026
Prefilled syringes have gained popularity owing to enhanced user safety, ease of use and the decline of potential dosage errors. At-home administration, self-administration and the surge of biologics are the primary aspects that trigger the growth of dual chamber prefilled syringes market. On account of low cost and adoption of self-administered drugs, conventional prefilled syringes are expected to be most preferred products in the market. Meanwhile, prefilled has become integral part of auto-injection segment of the drug delivery market, which needs prefilled cartridges.
Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs. Fact.MR’s report has listed key players augmenting the market expansion, which include Bespak Europe Ltd, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Inc., Schott AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Nipro Corporation, Boehringer Ingelheim GmbH, Amgen Inc., and Pfizer Inc.
Have Any Query?? Ask Our Industry Expert
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852